Austin-based business making strides toward Alzheimer’s disease treatment

AUSTIN (KXAN) –  An Austin-based pharmaceutical company is making promising strides toward developing a new treatment for Alzheimer’s disease. Cassava Sciences has been researching neurodegenerative conditions for over a decade. In a recent trial, one of their medications – simufilam – showed slowed cognitive decline by 38% in patients with mild-to-moderate Alzheimer’s disease who had the medication versus patients taking a placebo. “In my opini